Correction to “Impaired Autophagic Flux by Citalopram Inhibits DR5 Degradation and Increases TRAIL-Mediated Apoptosis”

IF 1.1 4区医学 Q3 PHARMACOLOGY & PHARMACY

Journal of Clinical Pharmacy and Therapeutics Pub Date : 2025-12-02 DOI:10.1155/jcpt/9816367

引用次数: 0

Abstract

K. M. A. Zinnah, A. N. Munna, J.-W. Seol, and S.-Y. Park, “Impaired Autophagic Flux by Citalopram Inhibits DR5 Degradation and Increases TRAIL-Mediated Apoptosis,” Journal of Clinical Pharmacy and Therapeutics, vol. 2025 (2025). https://doi.org/10.1155/jcpt/7538839.

In the article titled “Impaired Autophagic Flux by Citalopram Inhibits DR5 Degradation and Increases TRAIL-Mediated Apoptosis,” there was an error in Figure 1(j) related to an incorrect image being used to represent the morphology of the Calu-3 cells.

This error was introduced by the authors during figure assembly and should be corrected as follows:

We apologize for this error.

Abstract Image

查看原文本刊更多论文

对“西酞普兰抑制DR5降解并增加trail介导的细胞凋亡”的修正

K. M. A. Zinnah， A. N. Munna， J.-W。Seol和s - y。Park，“西酞普兰抑制DR5降解和增加trail介导的细胞凋亡的自噬通量受损”，《临床药学和治疗学杂志》，vol. 2025（2025）。https://doi.org/10.1155/jcpt/7538839.In在题为“西酞普兰抑制DR5降解并增加trail介导的细胞凋亡损害自噬通量”的文章中，图1(j)中有一个错误，与使用不正确的图像来表示Calu-3细胞的形态有关。此错误是由作者在图形组装过程中引入的，应按以下方式纠正：我们对此错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Pharmacy and Therapeutics 医学-药学

CiteScore

4.10

自引率

5.00%

发文量

226

审稿时长

6 months

期刊介绍： The Journal of Clinical Pharmacy and Therapeutics provides a forum for clinicians, pharmacists and pharmacologists to explore and report on issues of common interest. Reports and commentaries on current issues in medical and pharmaceutical practice are encouraged. Papers on evidence-based clinical practice and multidisciplinary collaborative work are particularly welcome. Regular sections in the journal include: editorials, commentaries, reviews (including systematic overviews and meta-analyses), original research and reports, and book reviews. Its scope embraces all aspects of clinical drug development and therapeutics, including: Rational therapeutics Evidence-based practice Safety, cost-effectiveness and clinical efficacy of drugs Drug interactions Clinical impact of drug formulations Pharmacogenetics Personalised, stratified and translational medicine Clinical pharmacokinetics.